Emmanuel Osayi

ORCID: 0000-0002-2337-596X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cervical Cancer and HPV Research
  • HIV/AIDS Research and Interventions
  • Genital Health and Disease
  • HIV, Drug Use, Sexual Risk
  • Adolescent Sexual and Reproductive Health
  • Reproductive tract infections research
  • Lipoproteins and Cardiovascular Health
  • HIV-related health complications and treatments
  • Global Cancer Incidence and Screening
  • Diabetes, Cardiovascular Risks, and Lipoproteins

AIDS Prevention Initiative in Nigeria
2023-2024

Initiatives (Denmark)
2023

We evaluated cervical cancer program for women living with HIV (WLHIV) to determine screening rate, primary case finder accuracy and treatment post-treatment rate among screen-positive patients.A ten-month review of data WLHIV aged 15-49 years on care across forty-one comprehensive ART sites, supported by APIN (a PEPFAR implementing partner) in Nigeria, was conducted from October 2020 July 2021. Initial done using visual inspection acetic acid (VIA) followed a gynaecologist expert through...

10.1186/s12978-023-01658-0 article EN cc-by Reproductive Health 2023-08-26

Internalized stigma, a condition characterized by negative self-stereotyping and social alienation, recently impacted the adolescents young adults living with HIV (AYLHIV) epidemic curve treatment adherence. While prior research has focused on impact of internalized stigma among HIV, few studies this AYLHIV. The study aims to determine proportion its relationship viral suppression in A cross-sectional involved 93 fully disclosed AYLHIV receiving care Faith Alive Foundation Jos North, Plateau...

10.1371/journal.pone.0303360 article EN cc-by PLoS ONE 2024-05-13

Background: Cervical cancer is the second most common among women in Nigeria and leading cause of cancer-related death sub-Saharan Africa. In low-income settings, visual inspections with acetic acid (VIA) Lugol’s iodine (VILI); subsequent treatment cervical precancerous lesions thermal ablation remains practical approach for secondary prevention. Objectives were to determine prevalence pre-cancerous lesions, suspected cancer, associated risk factors. Methods: A retrospective study on...

10.18203/2320-1770.ijrcog20232714 article EN International Journal of Reproduction Contraception Obstetrics and Gynecology 2023-08-29

Women and girls account for more than 50% of the global HIV population. In Nigeria, proportion women living with on long-term antiretroviral therapy (ART) has been rise. Despite this, little research exists their experiences regarding use, especially (WLHIV) in Plateau State, Nigeria. This study investigates barriers facilitators influencing use among HIV.

10.3390/ijerph21050546 article EN International Journal of Environmental Research and Public Health 2024-04-26

Understanding the time to hypertension occurrence after antiretroviral treatment (ART) initiation in people living with HIV (PLHIV) and its determinants is important for designing interventions control.

10.1177/20499361241289800 article EN cc-by-nc Therapeutic Advances in Infectious Disease 2024-01-01

Abstract We evaluated cervical cancer program for women living with HIV (WLHIV) to determine screening rate, primary case finder accuracy and treatment post-treatment rate among screen-positive patients. Methods A one-year review of data WLHIV aged 15-49 years on care across forty-one comprehensive ART sites supported by APIN (a PEPFAR implementing partner) in Nigeria was conducted from October 2020 July 2021. Initial done using visual inspection acetic acid (VIA) followed a gynaecologist...

10.21203/rs.3.rs-2485721/v1 preprint EN cc-by Research Square (Research Square) 2023-01-27

Background: Cervical cancer is the fourth most common among women globally, second in Nigeria and cause of cancer-related death Africa. In 2020, World Health Organization its updated guidelines recommended cervical screening using HPV DNA, mRNA tests subsequent treatment as appropriate. However, resource-poor settings, Visual Inspections with Acetic Acid (VIA), Lugol’s Iodine (VILI) precancerous lesions thermal ablation remain practical approaches. Objectives: To determine prevalence...

10.4236/ojog.2023.134068 article EN Open Journal of Obstetrics and Gynecology 2023-01-01

Cervical cancer accounts for 21.7% of all deaths in the sub-Saharan Africa with a case fatality rate 68%. Nigeria's Federal Ministry Health has adopted cervical screening (CCS) using visual inspection acetic acid or Lugol's iodine (VIA/VILI) and cryotherapy treatment precancerous lesions as preferred strategy. Using Exploration, Preparation, Implementation Sustainment Framework, our study documents experience during development, piloting roll-out APIN Public Initiatives (APIN)-developed VIA...

10.1136/bmjgh-2023-012311 article EN cc-by-nc BMJ Global Health 2023-07-01

Background: Cervical cancer is the second most common among women in Nigeria, and leading cause of cancer-related death sub-Saharan Africa. HIV-positive are at heightened risk developing cervical than HIV-negative due to immune suppression. In resource constrained settings, visual inspection with acetic acid (VIA) subsequent treatment precancerous lesions thermal ablation remains practical approach for secondary prevention. Objective: To compare prevalence suspected between HIV-infected on...

10.33545/26648393.2023.v5.i2a.20 article EN International Journal of Gynaecology Sciences 2023-01-01
Coming Soon ...